Tuberculosis

16 recommendations to help people facing disadvantages and barriers to accessing health care

Novel antibiotic disrupts peptidoglycan layer's structural integrity, forces autolysin release in Gram-positive bacteria

Rapid communication to update stakeholders on the changes in the drug-resistant TB detection options

Identifying shorter TB treatment regimens may reduce demands on health systems worldwide

Research advances the search for new medications to treat antibiotic-resistant infections

If no action is taken, antimicrobial resistance could cost the world’s economy US$ 100 trillion by 2050

The trial remains valuable for future research despite the unclear results

Thermostable vaccines are effective immunization options, especially when cold storage is inaccessible and/or expensive

This document updates the previous guide with the latest recommendations regarding new tools for diagnosis